The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

UnitedHealth Group Inc

NYSE: UNH
Last

(U.S.) $118.01

Today's change+1.76 +1.51%
Updated March 27 4:01 PM EDT. Delayed by at least 15 minutes.
 

UnitedHealth Group Inc

NYSE: UNH
Last

(U.S.) $118.01

Today's change+1.76 +1.51%
Updated March 27 4:01 PM EDT. Delayed by at least 15 minutes.

UnitedHealth Group Inc up sharply

UnitedHealth Group Inc closed up sharply Friday, rallying (U.S.)$1.76 or 1.51% to (U.S.)$118.01. Shares have lost 0.95% over the last five days, but sit 2.90% below their 52-week high. This security has outperformed the S&P 500 by 34.19% during the last year.

Key company metrics

  • Open(U.S.) $116.06
  • Previous close(U.S.) $116.25
  • High(U.S.) $118.22
  • Low(U.S.) $116.02
  • Bid / Ask-- / --
  • YTD % change+16.74%
  • Volume2,608,526
  • Average volume (10-day)4,118,676
  • Average volume (1-month)3,670,871
  • Average volume (3-month)4,131,595
  • 52-week range(U.S.) $73.61 to (U.S.) $121.53
  • Beta0.62
  • Trailing P/E20.85×
  • P/E 1 year forward18.74×
  • Forward PEG1.95×
  • Indicated annual dividend(U.S.) $1.50
  • Dividend yield1.27%
  • Trailing EPS(U.S.) $5.66
Updated March 27 4:01 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue33,43332,75932,57431,708
Total other revenue--------
Total revenue33,43332,75932,57431,708
Gross profit--------
Total cost of revenue--------
Total operating expense30,66829,85630,02229,654
Selling / general / administrative5,8455,4365,2065,194
Research & development--------
Depreciation / amortization381373364360
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total24,44224,04724,45224,100
Operating income2,7652,9032,5522,054
Interest income (expense), net non-operating-151-152-155-160
Gain (loss) on sale of assets--------
Other--------
Income before tax2,6142,7512,3971,894
Income after tax1,5101,6021,4081,099
Income tax, total1,1041,149989795
Net income1,5101,6021,4081,099
Total adjustments to net income--------
Net income before extra. items1,5101,6021,4081,099
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,5101,6021,4081,099
Inc. avail. to common incl. extra. items1,5101,6021,4081,099
Diluted net income1,5101,6021,4081,099
Dilution adjustment--------
Diluted weighted average shares1,013982991983
Diluted EPS excluding extraordinary itemsvalue per share1.491.631.421.12
Dividends per sharevalue per share0.380.380.380.28
Diluted normalized EPSvalue per share1.491.631.421.12